Opening Bell Analysts Research Calls for Tuesday, March 28
This report was sent to Briefing.com subscribers earlier today. Research calls posted earlier this morning are available here. Upgrades: > Coherus BioSciences (CHRS) upgraded to Buy from Neutral at UBS; tgt $11 > Otsuka (OTSKY) upgraded to Buy from Hold…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
This report was sent to Briefing.com subscribers earlier today.
Research calls posted earlier this morning are available here.
Upgrades:
> Coherus BioSciences (CHRS) upgraded to Buy from Neutral at UBS; tgt $11
> Otsuka (OTSKY) upgraded to Buy from Hold at Jefferies
> William Demant Holding (WILYY) upgraded to Equal-Weight from Underweight at Morgan Stanley
Downgrades:
> JBS SA (JBSAY) downgraded to Equal Weight from Overweight at Barclays
Others:
> Restaurant Brands Int’l (QSR) assumed with a Sector Outperform at Scotiabank; tgt $72
Contact [email protected] for any questions or corrections.
Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.
He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.